TATVA logo

Tatva Chintan Pharma Chem Limited Stock Price

NSEI:TATVA Community·₹25.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author
Create a narrative

TATVA Share Price Performance

₹1,276.60
274.60 (27.41%)
6.4% overvalued intrinsic discount
₹1,200.00
Fair Value
₹1,276.60
274.60 (27.41%)
6.4% overvalued intrinsic discount
₹1,200.00
Fair Value
Price ₹1,276.60
AnalystHighTarget ₹1,200.00
AnalystConsensusTarget ₹833.67
AnalystLowTarget ₹535.00

TATVA Community Narratives

AnalystHighTarget·
Fair Value ₹1.2k 6.4% overvalued intrinsic discount

Eco-friendly Specialty Chemicals Will Drive Global Market Expansion

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·
Fair Value ₹865 47.6% overvalued intrinsic discount

Overvaluation Risks And Emerging Sectors Will Shape Future Dynamics

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystLowTarget·
Fair Value ₹535 138.6% overvalued intrinsic discount

Rising ESG Pressures And Localization Will Erode Export Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent TATVA News & Updates

Is Tatva Chintan Pharma Chem (NSE:TATVA) Using Too Much Debt?

Sep 30
Is Tatva Chintan Pharma Chem (NSE:TATVA) Using Too Much Debt?

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) P/S Is Still On The Mark Following 25% Share Price Bounce

May 24
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) P/S Is Still On The Mark Following 25% Share Price Bounce

Tatva Chintan Pharma Chem Limited Key Details

₹3.9b

Revenue

₹2.0b

Cost of Revenue

₹1.9b

Gross Profit

₹1.9b

Other Expenses

₹71.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
3.06
Gross Margin
49.18%
Net Profit Margin
1.82%
Debt/Equity Ratio
4.9%

Tatva Chintan Pharma Chem Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
1 Reward
View Full Analysis

About TATVA

Founded
1996
Employees
679
CEO
Chintan Shah
WebsiteView website
www.tatvachintan.com

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

Market Insight

Header cover image

📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead

Richard Bowman avatarRichard Bowman
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Last Week
✨Rare Earths: Tiny Market, Outsized Influence

✨Rare Earths: Tiny Market, Outsized Influence

Indian Market Performance

  • 7 Days: -0.6%
  • 3 Months: -1.7%
  • 1 Year: -5.5%
  • Year to Date: 0.7%
The market has been flat over the last week. As for last year, the market is down 5.5%. Looking forward, earnings are forecast to grow by 16% annually. Market details ›